ENHANCEMENTS IN RECOMBINANT HUMAN SERUM ALBUMIN FOR BIOPHARMACEUTICAL PROGRAMS

Recombinant human serum albumin (OsrHSA) has emerged as a significant innovation in the sphere of biopharmaceuticals, giving promising enhancements across several health-related and industrial programs. With its structural similarity to naturally derived human serum albumin, OsrHSA supplies a safer, extra dependable substitute for therapeutic use,